Aura Biosciences (AURA) Stock Forecast & Price Target

AURA$7.110.00 0.00%
BiotechnologyGrowth Stock
Compare
Market cap$739.97MEnterprise value$767.84MRevenue (TTM)$0Market position—

Score

67
Bullish
Value
53
Quality
48
Growth
100

Aura Biosciences, Inc. price target

AURA
Low$17.00
Average$17.50
High$18.00
Upside vs current price+146.1%

The average target of $17.50 is +146.1% versus the current AURA price of $7.11.

Aura Biosciences, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy5
Hold0
Sell0
Strong sell0
ConsensusBuy

6 analysts cover AURA.

Aura Biosciences, Inc. EPS and revenue estimates

AURA shows the next fiscal years with at least three analysts: 2026 EPS $-1.67, 2027 EPS $-1.52. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-1.67$19.20M
2027$-1.52$4.92M

Is Aura Biosciences, Inc. a buy or sell?

Of the 6 analysts covering Aura Biosciences, Inc., 6 rate it a buy (1 strong buy and 5 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The AURA consensus label is Buy, beside 6 buy-side ratings and 0 sell-side ratings.

The average target of $17.50 implies +146.1% versus the current price of $7.11.

Those 6 ratings on AURA are a headcount, and the label on file is Buy.

Reading the Aura Biosciences, Inc. forecast

The AURA targets sit in a narrow band, from $17.00 to $18.00, around an average of $17.50.

Set next to the $7.11 AURA quote, that average is +146.1%.

Ratings on the Aura Biosciences, Inc. cluster: 6 of 6 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The AURA EPS path from 2026 ($-1.67) to 2027 ($-1.52) is rising.

Only 6 analysts cover AURA, so the average rests on a short list.

Aura Biosciences, Inc. forecast questions

What is the AURA price target?

The published range for AURA is $17.00 to $18.00, with an average of $17.50. That average is +146.1% versus the current price of $7.11.

Is Aura Biosciences, Inc. a buy or sell?

Of the 6 analysts covering Aura Biosciences, Inc., 6 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the AURA headcount is 6 buy, 0 hold, and 0 sell.

What is the EPS estimate for Aura Biosciences, Inc.?

Analyst EPS estimates for Aura Biosciences, Inc.: 2026 $-1.67, 2027 $-1.52.

What is the revenue estimate for Aura Biosciences, Inc.?

Analyst revenue estimates for Aura Biosciences, Inc.: 2026 $19.20M, 2027 $4.92M.

How many analysts cover AURA?

6 analysts cover AURA. Their consensus on AURA is Buy, across those 6.

AURA price $7.11 0.00 0.00%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener